Abrdn PLC Geron Corp Transaction History
Abrdn PLC
- $51.7 Billion
- Q4 2024
A detailed history of Abrdn PLC transactions in Geron Corp stock. As of the latest transaction made, Abrdn PLC holds 1,847,285 shares of GERN stock, worth $4.42 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,847,285
Previous 1,487,258
24.21%
Holding current value
$4.42 Million
Previous $6.75 Million
3.15%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding GERN
# of Institutions
306Shares Held
465MCall Options Held
1.07MPut Options Held
648K-
Black Rock Inc. New York, NY46.6MShares$111 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA33.5MShares$80.2 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA30MShares$71.7 Million1.72% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$65.1 Million18.81% of portfolio
-
State Street Corp Boston, MA27.2MShares$64.9 Million0.0% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $903M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...